Global Financial Private Client’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9
Closed -$72 1435
2025
Q1
$72 Buy
9
+4
+80% +$40 ﹤0.01% 1628
2024
Q4
$45 Buy
+5
New +$48 ﹤0.01% 1596
2021
Q4
Sell
-28
Closed -$3.55K 650
2021
Q3
$3.55K Sell
28
-8
-22% -$1.17K ﹤0.01% 418
2021
Q2
$5.93K Sell
36
-631
-95% -$102K ﹤0.01% 398
2021
Q1
$122K Buy
667
+62
+10% +$14.4K 0.09% 137
2020
Q4
$121K Buy
605
+127
+27% +$25.8K 0.1% 125
2020
Q3
$105K Buy
+478
New +$101K 0.09% 128

Other funds holding TDOC

Global Financial Private Client's TDOC Position: Q2 2025 in Review

Global Financial Private Client sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 9 shares — an estimated $72 sold.

Global Financial Private Client first reported a position in TDOC in Q3 2020 and held it in 7 quarters. The position peaked at $122K in Q1 2021. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Global Financial Private Client reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 9 Teladoc Health shares in Q2 2025, an estimated $72.
  • Global Financial Private Client first reported a position in Teladoc Health in Q3 2020 and held it in 7 quarters.
  • Global Financial Private Client's Teladoc Health position peaked at $122K in Q1 2021.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.